Compugen CGEN
NASDAQ CGEN
$1.94 -0.02 (-1.02%)
As of: Oct 23, 2026 · 3:59 PM EDT

Compugen (CGEN) Gains from Sales and Divestitures (2009 - 2010)

Updated

Compugen (CGEN) reported Gains from Sales and Divestitures of $1,000 for FY2025.

Analysis

Compugen (CGEN) Gains from Sales and Divestitures (2009 - 2010) Analysis & Trends

Dating back to FY2009, Compugen's Gains from Sales and Divestitures record includes 10 years.

  • Gains from Sales and Divestitures has a five-year compound annual growth rate of -39.2% (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual Gains from Sales and Divestitures since FY2021.
  • According to Business Quant data, Gains from Sales and Divestitures came in at -$7,000 in FY2023, -$12,000 in FY2022 and $3,000 in FY2021 (-75.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Compugen 179.84 Mn -193.24 Mn -92,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 50,000.00
Sep 30, 2010 -11,000.00
Dec 31, 2009 180,000.00
Sep 30, 2009 28,000.00
API Access

Compugen Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CGEN&period=max&api_key=YOUR_API_KEY